Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Relations Dept News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Relations Dept. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Relations Dept Today - Breaking & Trending Today
Former Boeing Rotorcraft Director Joins Xeriant's Board of
Col. John “Bones” Parker (Ret.) brings expertise in rotorcraft and foreign military sales...
Source: globenewswire.com
Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Actuate Therapeutics Announces Initiation of a Multicenter
Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General Hospital, Fred...
Source: globenewswire.com